Evidence map›Paper›PMID 22013069›Full record

ArticleThe Journal of biological chemistry2011

Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.

Michael Helwig, Sang-Nam Lee, Jae Ryoung Hwang, Akihiko Ozawa, Juan F Medrano, Iris Lindberg

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michael HelwigDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Sang-Nam LeeResearch Center for Natural Human Defense System, Yonsei University College of Medicine, Seoul 120-752, Korea.
Jae Ryoung HwangMolecular Therapy Research Center, Sungkyunkwan University, Seoul 135-710, Korea.
Akihiko OzawaDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Juan F MedranoDepartment of Animal Science, University of California, Davis, California 95616-8521.
Iris LindbergDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201. Electronic address: ilind001@umaryland.edu.
University of Maryland, Baltimore · USSungkyunkwan University · KRUniversity of California, Davis · USYonsei University · KR

Funding

CONTROL OF PEPTIDE HORMONE BIOSYNTHESIS BY PC2 AND 7B2R01DK049703 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDBERG, IRIS · 1996 to 2012
$3.7M
NIDDK NIH HHS DK49703NIDDK NIH HHS R01 DK049703
6 · The paper itself

Abstract

The small neuroendocrine protein 7B2 is required for the production of active prohormone convertase 2 (PC2), an enzyme involved in the synthesis of peptide hormones, such as glucagon and proopiomelanocortin-derived α-melanocyte-stimulating hormone. However, whether 7B2 can dynamically modulate peptide production through regulation of PC2 activity remains unclear. Infection of the pancreatic alpha cell line α-TC6 with 7B2-encoding adenovirus efficiently increased production of glucagon, whereas siRNA-mediated knockdown of 7B2 significantly decreased stored glucagon. Furthermore, rescue of 7B2 expression in primary pituitary cultures prepared from 7B2 null mice restored melanocyte-stimulating hormone production, substantiating the role of 7B2 as a regulatory factor in peptide biosynthesis. In anterior pituitary and pancreatic beta cell lines, however, overexpression of 7B2 affected neither production nor secretion of peptides despite increased release of active PC2. In direct contrast, 7B2 overexpression decreased the secretion and increased the activity of PC2 within α-TC6 cells; the increased intracellular concentration of active PC2 within these cells may therefore account for the enhanced production of glucagon. In line with these findings, we found elevated circulating glucagon levels in 7B2-overexpressing cast/cast mice in vivo. Surprisingly, when proopiomelanocortin and proglucagon were co-expressed in either pituitary or pancreatic alpha cell lines, proglucagon processing was preferentially decreased when 7B2 was knocked down. Taken together, these results suggest that proglucagon cleavage has a greater dependence on PC2 activity than other precursors and moreover that 7B2-dependent routing of PC2 to secretory granules is cell line-specific. The manipulation of 7B2 could therefore represent an effective way to selectively regulate synthesis of certain PC2-dependent peptides.

Indexed as

AnimalsCell LineFemaleGlucagonIslets of LangerhansMaleMiceNeuroendocrine Secretory Protein 7B2PancreasPeptidesPituitary GlandPro-OpiomelanocortinProprotein Convertase 2Protein Processing, Post-TranslationalRNA InterferenceGlucagonNeuroendocrine Secretory Protein 7B2PeptidesPro-OpiomelanocortinProprotein Convertase 2

Identifiers

PMID22013069
PMCPMC3234932
OpenAlexW2086053237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.